文献速递关节外科创伤骨科

经腓骨入路全踝关节置换术在年轻与老年患者中的7年临床与影像学结果

Clinical and Radiographic Outcomes at a Mean of 7 Years Following Primary Transfibular Total Ankle Arthroplasty in Younger and Older Patients.
PubMed 文献 · J Bone Joint Surg Am · 2026-06-18

本研究比较了55岁以下与55岁及以上患者经腓骨入路初次全踝关节置换术的中期假体生存率及临床与影像学结果。

要点

  • 经腓骨入路全踝关节置换术在年轻与老年患者中中期假体生存率及临床结果相似。
  • 年轻组创伤后关节炎及踝关节骨折固定史比例更高(83% vs 61%,84% vs 68%)。
  • 两组不良事件率(40.3% vs 33.0%)、翻修率(1.4% vs 0%)及假体周围囊肿(5.6% vs 2.8%)无显著差异。

核心结论

  • 经腓骨入路全踝关节置换术在年轻和老年患者中均观察到良好的中期结果,可能适用于广泛年龄范围的终末期踝关节炎,但需更长期随访。

主要发现

  • 年轻组平均年龄45.4岁(95%CI 43.7-47.1),平均随访6.9年(95%CI 6.2-7.5);老年组平均年龄65.7岁(95%CI 64.7-66.7),平均随访7.0年(95%CI 6.7-7.3)。
  • 年轻组创伤后关节炎(83% vs 61%)和踝关节骨折固定史(84% vs 68%)比例更高(p<0.05)。
  • 两组不良事件率(40.3% vs 33.0%)、再手术时间(21.7 vs 27.4个月)、假体翻修率(1.4% vs 0%)及假体周围囊肿(5.6% vs 2.8%)无显著差异。
  • 控制混杂变量后,年龄与术前或术后PROMs、对线或活动度均无显著关联(所有p>0.05)。

关键数值与推荐

  • 假体周围囊肿定义为影像学透亮区>2mm。
  • 患者报告结局指标包括SF-12、AOS和VAS疼痛评分。

临床怎么用

  • 经腓骨入路全踝关节置换术可考虑用于年轻终末期踝关节炎患者,但需个体化评估并告知需长期随访。

局限性

  • 本研究非等效性设计,无法确定两组间等效性。
  • 需要更长期随访以评估假体耐久性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total ankle arthroplasty (TAA), traditionally performed through an anterior approach, has generally been reserved for older patients. A lateral transfibular approach requires minimal osseous resection and permits implantation into denser bone, which may make it a durable option for younger candidates. This study compared midterm implant survivorship and clinical and radiographic outcomes following primary transfibular TAA in patients younger and older than 55 years. METHODS: Patients who underwent primary transfibular TAA and had a minimum follow-up of 5 years were included. Patient-reported outcome measures (PROMs) included the 12-Item Short-Form Health Survey (SF-12), Ankle Osteoarthritis Scale (AOS), and visual analog scale (VAS) for pain. Radiographic alignment, range of motion, and periprosthetic cysts (radiolucency of >2 mm) were assessed. Adverse events and reoperations were reported. Outcomes in younger (<55 years old) and older (≥55 years old) patients were compared using multivariable linear regression and linear mixed models. RESULTS: Two hundred and fifty-one ankles (in 236 patients; 86% White) were included. The younger group included 72 ankles (in 70 patients, mean age of 45.4 years [95% confidence interval (CI), 43.7 to 47.1] years) with a mean of 6.9 (6.2 to 7.5) years of follow-up; the older group included 179 ankles (in 166 patients, mean age of 65.7 years [64.7 to 66.7] years) with a mean of 7.0 (6.7 to 7.3) years of follow-up. The younger group more commonly had a primary diagnosis of posttraumatic arthritis (83% versus 61%) and a history of ankle fracture fixation (84% versus 68%) (both p < 0.05). There were no significant differences between the younger and older groups in the rate of adverse events (40.3% versus 33.0%), time to reoperation (21.7 versus 27.4 months), implant revision (1.4% versus 0%), or periprosthetic cysts (5.6% versus 2.8%). In analyses controlling for confounding variables, age did not demonstrate significant associations with pre- or postoperative PROMs, alignment, or range of motion (all p > 0.05). CONCLUSIONS: Although this study was not designed to determine equivalence between the age groups, favorable midterm outcomes were observed in both younger and older patients. These results suggest that transfibular TAA may be a viable treatment option for end-stage ankle arthritis across a wide age range, but longer-term follow-up is needed. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Schafer KA, Day J, Motsay M, et al. Clinical and Radiographic Outcomes at a Mean of 7 Years Following Primary Transfibular Total Ankle Arthroplasty in Younger and Older Patients. J Bone Joint Surg Am. 2026. PMID: 42359899. doi:10.2106/JBJS.25.00941

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。